Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, že xxx 16. xxxxxxxxx 2007 xxxx xxxxxxxxxx xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x metod xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx v xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2008 x xxxxx xxxx xxxxxxxxx x xxxxxxxx i xxx Xxxxxx xxxxxxxxx. Dnem xxxxxx Přílohy X x xxxxxxxx xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx proti xxxxxxx ve xxxxxx xx znění xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Přílohy X a xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; boldion (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-dimetyl-5α-androstan-3-on-17β-ol); xxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9-dien-3-on); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); methylnortestosteron (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); methyltestosteron; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; oxymetolon; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-testosteron (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx nebo podobnými xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), dihydrotestosteron, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX), testosteron x xxxxxxxxxxx xxxxxxxxxx x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx steroid xxxxxxxxx, xxxx xx xxx xx to, xx Xxxxxx obsahuje xxxx Xxxxxxxxx xxxxx x xxxx hlášen pozitivní Xxxxxxxxx laboratorní xxxxx, xxxx xx koncentrace Xxxxxxxx xxxxx nebo xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx xxxx xxxxxxxxx poměr xx Xxxxxx Sportovce významně xxxxxxxxx xx xxxxxxx xxxxxx, které se xxxxxxxx xxxxxxxxx x xxxx xxx, xx xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, pokud Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Zakázané xxxxx nebo xxxxxx xxxxxxxxxx nebo xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Vzorku Xxxxxxxxx xxxxxxxx fyziologickým xxxx xxxxxxxxxxxx stavem.

Xxxx xx xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Zakázanou xxxxx a xxxxxxxxx xxxxxxx Pozitivní xxxxxxxxxxx xxxxx ve všech xxxxxxxxx x xxx xxxxxxxxx koncentraci, pokud xxx podle xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx, xx xx Xxxxxxxx látka xxxxxxxxxx xxxxxx. X xxxxxxx případě xxxx xxxxx provádět další xxxxxxx.

Když se xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx látky, xxxx xxxx. porovnání x xxxxxxxxxxx xxxxxxxxxxxx steroidními xxxxxxx, nebo xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx xxx xxxxx (4) xx xxxxx (1) a xxxxx xxxxxxxxxx analytická xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ xxxxx, provede příslušná Xxxxxxxxxxxxx organizace xxxxx xxxxxxx porovnáním výsledků xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, pak xxxxxxxx bude xxxxxxxxxx xxxxxx jako neobvyklý x xx jako xxxxxxxxx. Pokud xxxxxxxxx xxxxxxx, za xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxx xxxxx Xxxxxxxx látky, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx to, že Xxxxxx obsahuje Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx spolehlivá analytická xxxxxx (např. XXXX) x xxxxxx x xxxxxxxxx minimálně 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx tím, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx bez předchozího xxxxxxxx. Xxxxxxxx, který xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx profil Sportovce, xxxxxxxx následnými testy, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx xxxxxx xxxxxxx boldenon xxxxxxxxxxx xxxxxx xx velice xxxxxx xxxxxxxxxxxxx (ng/ml). Xxxxx laboratoř takový xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, může xxx provedeno další xxxxxxx provedením xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, xxxx se xx xxxxxxxxx xx xxxxxxx x xxxxxxxxxxx xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

V případě, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, bude xx xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Xxxxxxxxx látku.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Klenbuterol, xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), tibolon, xxxxxxx, zilpaterol, xxx xx s xxxxxxxx xxxxx xx xx.

X2. XXXXXXX X PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx xxxxx x jejich xxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx xxxxxx (xXX), insulinu podobné xxxxxxx faktory (např. XXX-1), mechanické růstové xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (např. LH, xXX), xxxxxxxx jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, bude xx xxx xx xx, xx Xxxxxx xxxxxxxx Zakázanou xxxxx (xxx xx xxxxxxx xxxx) v případech, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxxx xx Xxxxxx Xxxxxxxxx xxxxxxx překročí hodnoty xxxxxxxx xxxxxxxx x xxxx xxx, že xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx.

Xxxxx xxxxxxxxx xxxxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx původu, xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx a bude xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 agonisté xxxxxx xxxxxx X- a X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, xxx které xx xxx xxxxxxxx xxxxx udělení zkrácené xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx udělena xxxxxxxx xxxxx terapeutické xxxxxxx, xxxx xxxxx xxxxxxxxxxx (volný xxxx xxxxxxxxxx) xxxxx než 1000 nanogramů x 1 xxxxxxxxx xxxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, pokud Xxxxxxxxx xxxxxxxxx, xx xxxxxxxxxx xxxxxxxx byl xxxxxxxx xxxxxxxxxxxxx užíváním xxxxxxxxxxx v xxxxxxxx.

X4. XXXXXXXXXXX X XXXXXXXXXX XXXXXXX

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Inhibitory xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxx včetně inhibitorů xxxxxxxxxx, xxx xx x xxxxxxxx pouze xx xx.

X5. XXXXXXXXX A XXXXXXX XXXXXXXXX LÁTKY

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, probenecid, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, dutasterid), plasmaexpandery (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) x další xxxxx s xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, chlortalidon, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, chlorothiazid), xxxxxxxxxx x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx není xxxxxx, xxxxx moč Sportovce xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx podprahovou xxxxxxxx xxxx Xxxxxxxx látky (xxxxx).

X1. ZVYŠOVÁNÍ XXXXXXX XXXXXXX

Zakázané je xxxxxxxxxxx:

M2. CHEMICKÁ X XXXXXXXXX MANIPULACE

X3. XXXXXX XXXXXX

Xxxxxxxxxxxxxx xxxxxxx xxxxx, genů, xxxxxxxx elementů, xxxx xxxxxxxxxx xxxxxxx xxxx, xxxxx xxxx schopnost xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- a L-) xxxxxxx) xxxx zakázaná, x xxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxx xxxxxx xxxxxxxx xxxxx x stimulancií xxxxxxxxxx xx Xxxxxxxxxxxxxx xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx xxxxxxxx:

Adrafinil, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, benzfetamin, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, etamivan, xxxxxxxxx, ethylamfetamin, xxxxxxxxxxx, xxxxxxxxxxx, fendimetrazin, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (karfedon), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, xxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, methylendioxymetamfetamin, methylfenidát, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, norfenfluramin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, propylhexedrin, selegilin, xxxxxxxxxx, strychnin, xxxxxxxxxxxxx x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxxxxx neuvedené výslovně xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx za specifickou xxxxx pouze, pokud Xxxxxxxxx prokáže, že xxxx xxxxxxxxx xxxxxxxxxx x běžných léčebných xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxx je x xxx xxxxx xxxxxxxxxxxxxxx, xx xxxx úspěšně xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, morfin, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Kanabinoidy (xxxx. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxx, rektálně, xxxxxxxxxx xxxx xxxxxxxxxxxxx xxxxxxxx xxxx zakázané. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx xxxxxxxx aplikace (xxxxxxxxxxxx, do okolí xxxxxx, xx xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) a xxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx výjimku x xxxxxxxx xxxx uvedených.

Xxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, oční, potíže xxxxx řitního xxxxxx, xxxxxxxx úst x xxxxx xxxxxx xxxxxxxx x nevyžadují xxxxxx xxxxx xxxxxxxxxxxx xxxxxxx.

P1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx xxxxx Xxx xxxxxxx v xxxxxxxxxxxxx xxxxxxxx. Detekce xx xxxx provádět xxxxxxxx zkouškou x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) je pro xxxxxx xxxxxxxx uvedena x xxxxxxxxx.

∙ Xxxxxxxxxxxx sport (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 x/x)

∙ Moderní xxxxxxx (XXXX) jen xxx xxxxxxxxxx se střelbou (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Kuželky (IPC) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Xxx soutěži x xxxxxxxxxxxxx sportech.

∙ Automobilový xxxxx (XXX)

∙ Billiard (XXXX)

∙ Xxxx (XXXX)

∙ Bridž (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxxxxx (FIS) - skoky na xxxxxx a xxxxxxxxxxx xxxxxxxx-xxxxx a X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx se střelbou

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, IPC "xxxxx")

∙ Xxxxxxx (ISSF, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Xxxxx motorismus (XXX)

∙ Xxxxx (FILA)

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Acebutolol, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx xxxxx na xx

"Specifické xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx xxxxxxxxxxx (volného xxxx glukuronidu) xxx xxxxxxxx větším než 1000 xx/xx xxxx x xxxxxxxxxxxx (zařazen xx skupině S 1.2 Xxxxxxx anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx a všechna xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx x oddíle X6, pro která Xxxxxxxxx xxxxxxx, že xxxxxxx podmínky xxxxxxx x xxxxxx S6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Glukokortikosteroidy;

∙ Xxxxxxx;

∙ Všechny Xxxx-xxxxxxxxx.

*"V Seznamu xxxxx být xxxxxxxxxxx xxxxxxxxxx látky, xxxxx xxxxxxxx umožňuji xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxxxxx xxxx xxxxxxxxx xxxxxxxx v běžných xxxxxxxxx přípravcích, xxxx x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx xxxxxxx xxxxxxxx xxxx dopingová činidla." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx takovéto xxxxx xxxx znamenat xxxxxxx xxxxxx za xxxxxxxxxxx, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, xx Xxxxxxx xxxxxxxxxx xxxxx xxxxxx xxxxxxxxx ke xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx xxxxxxx č. 2/2008 Sb. x. x. nabyl xxxxxxxxx xxxx 31.1.2008.

Xxxxxx předpis x. 2/2008 Sb. x. x. byl xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx předpisu.